A detailed history of Algert Global LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Algert Global LLC holds 64,125 shares of EW stock, worth $4.75 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
64,125
Previous 4,616 1289.19%
Holding current value
$4.75 Million
Previous $426,000 893.43%
% of portfolio
0.11%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$59.7 - $93.78 $3.55 Million - $5.58 Million
59,509 Added 1289.19%
64,125 $4.23 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $107,904 - $120,716
1,280 Added 38.37%
4,616 $426,000
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $308,440 - $406,321
-4,252 Reduced 56.04%
3,336 $319,000
Q4 2023

Feb 14, 2024

BUY
$61.71 - $77.76 $59,179 - $74,571
959 Added 14.47%
7,588 $579,000
Q3 2023

Nov 13, 2023

SELL
$69.28 - $93.38 $793,671 - $1.07 Million
-11,456 Reduced 63.35%
6,629 $459,000
Q1 2023

May 12, 2023

BUY
$74.26 - $84.51 $391,350 - $445,367
5,270 Added 41.12%
18,085 $1.5 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $555,757 - $711,499
8,137 Added 173.94%
12,815 $956,000
Q3 2022

Nov 15, 2022

BUY
$82.37 - $107.29 $6,507 - $8,475
79 Added 1.72%
4,678 $387,000
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $397,813 - $589,913
4,599 New
4,599 $437,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $615,838 - $775,173
-6,040 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$106.37 - $130.68 $853,193 - $1.05 Million
-8,021 Reduced 57.04%
6,040 $782,000
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $1.45 Million - $1.73 Million
14,061 New
14,061 $1.59 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.